OPKO Health, Inc.
OPKO Health, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants | metabolic dysfunction-associated steatohepatitis | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT07512427 | |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants | endocrine system disorder, hyperparathyroidism, parathyroid gland disorder, secondary hyperparathyroidism | Recruiting | Phase 2 | 2026-08-20 | NCT07494045 |